Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU considers single patent and life sciences strategy

This article was originally published in Clinica

Executive Summary

The establishment of "a single patent for a single market" and the review of a progress report on the EU's life science and biotechnology strategy were at the centre of this week's meeting of the Competitiveness Council of Ministers. The growing clamour for a policy that supports EU innovation as the next framework programmes (FP6 and FP7) come on stream is backed by a petition signed by more than 300 CEOs and research directors.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel